- Home
- SEMR vs CPRX Comparison
SEMR vs CPRX Comparison
Compare SEMR & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEMR
- CPRX
- Stock Information
- Founded
- SEMR 2008
- CPRX 2002
- Country
- SEMR United States
- CPRX United States
- Employees
- SEMR N/A
- CPRX N/A
- Industry
- SEMR EDP Services
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- SEMR Technology
- CPRX Health Care
- Exchange
- SEMR Nasdaq
- CPRX Nasdaq
- Market Cap
- SEMR 2.6B
- CPRX 2.6B
- IPO Year
- SEMR 2021
- CPRX 2006
- Fundamental
- Price
- SEMR $10.07
- CPRX $25.88
- Analyst Decision
- SEMR Buy
- CPRX Strong Buy
- Analyst Count
- SEMR 7
- CPRX 8
- Target Price
- SEMR $18.71
- CPRX $32.50
- AVG Volume (30 Days)
- SEMR 950.2K
- CPRX 1.6M
- Earning Date
- SEMR 05-05-2025
- CPRX 05-07-2025
- Dividend Yield
- SEMR N/A
- CPRX N/A
- EPS Growth
- SEMR 747.54
- CPRX 107.94
- EPS
- SEMR 0.06
- CPRX 1.31
- Revenue
- SEMR $376,815,000.00
- CPRX $491,734,000.00
- Revenue This Year
- SEMR $22.30
- CPRX $15.17
- Revenue Next Year
- SEMR $19.65
- CPRX $8.28
- P/E Ratio
- SEMR $177.82
- CPRX $19.63
- Revenue Growth
- SEMR 22.47
- CPRX 23.49
- 52 Week Low
- SEMR $9.21
- CPRX $14.47
- 52 Week High
- SEMR $18.74
- CPRX $26.16
- Technical
- Relative Strength Index (RSI)
- SEMR 35.19
- CPRX 72.85
- Support Level
- SEMR $9.74
- CPRX $20.68
- Resistance Level
- SEMR $10.24
- CPRX $21.42
- Average True Range (ATR)
- SEMR 0.43
- CPRX 0.83
- MACD
- SEMR 0.19
- CPRX 0.45
- Stochastic Oscillator
- SEMR 67.39
- CPRX 92.95
About SEMR SEMrush Holdings Inc.
SEMrush Holdings Inc is engaged in the provision of an online visibility management software-as-a-service platform. Its platform enables subscribers to improve their online visibility and drive traffic, including on their websites and social media pages, and distribute highly relevant content to their customers on a targeted basis across various channels to drive high-quality traffic and measure the effectiveness of their digital marketing campaigns. Geographically, it generates revenues from the US, the UK, and other regions.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.